Samuel R Denmeade

27PUBLICATIONS
128CO-AUTHORS
Molecular targetsPredictive and prognostic markersPeripheral nervous systemRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 30, 2026
Immunometabolic effects of oral testosterone for castration-resistant prostate cancer in the ACROBAT trial.

|Apr 08, 2026
Castration Resistance Accelerates Prostate Cancer Kinetics.

Sheila Jonnatan, Luka Cavka, Angelo M De Marzo

|Feb 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.

Madelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh

|Nov 21, 2025
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer.

Rajendra Kumar, Sheila Jonnatan, David E Sanin

|May 07, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

|Jan 28, 2025
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.

Rajendra Kumar, Janet Mendonca, Abhishek Shetty

Pageof 5

Frequent Collaborators

10 joint publications

Channing J Paller

9 joint publications

Mark Markowski

9 joint publications

Emmanuel S Antonarakis

8 joint publications

Catherine H Marshall